Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin

News   Jan 07, 2014

 
Adocia Launches Phase IIa Clinical Trial for its Ultra-fast Acting Formulation of Analog Insulin
 
 
FURTHER INFORMATION
 
 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE